Guangming District-based enterprise Salus Medical introduced its latest contribution to the field of genetic research: the Salus EVO high-throughput sequencer, at the 10th Next Generation Sequencing Conference in Beijing, Bao'an Daily reported.
This new device brings together several proprietary technologies to excel in both speed and data processing, setting a fresh industry benchmark for sequencing equipment.
Zhao Luyang, CEO of Salus Medical, shared during the product's debut that gene sequencing is undergoing a monumental shift. With 2024 marking a pivotal year, advancements in sequencing technologies are changing the landscape of genetic analysis. There's a boom in the use of sequencing for clinical diagnostics, and applications are spreading across the board, from agriculture to consumer markets. Modern demands, partly driven by AI milestones like ChatGPT and SORA, call for sequencing devices that are faster and more powerful. Until now, the market has struggled with inefficiencies such as lengthy sample preparation and clunky, costly machinery.
The Salus EVO stands out with its custom-engineered optics, high-performance biochemical systems, and enhanced sequencing enzymes. This powerhouse supports advanced chip technology, offers multiple data-read options, and can output an impressive 75GB to 2,000GB of data within a mere 8 to 24 hours, thereby achieving a remarkable synergy of capacity and rapidity.
On top of its superior sequencing capabilities, the Salus EVO brings to the table user-friendly advancements including automated features, ease of operation, and consistent reliability. Its sleek design takes up less than a square meter of space and presents a minimal footprint ideal for most lab setups. Rigorous testing has shown that the Salus EVO not only delivers top-tier data quality, but outperforms its competitors in several key areas, offering both cost-effectiveness and operational superiority.
Zhao views the Salus EVO as a strategic milestone for Salus Medical, signaling the company's dedication to encompassing all levels of sequencing needs from low to high capacity.